FGF2 and infection: No significant differences in infection rates were evident between the ofloxacin drops and observation groups (P = .477), the FGF-2 and observation groups (P = .099), the FGF-2 and ofloxacin drops groups (P = .324), or the EGF and FGF-2 groups (P = .065).